29 Jul 2012
(MENAFN) Ras AL Kaimah-based generic drug maker Gulf Pharmaceutical Industries (Julphar) reported year-on-year 8.2 percent increase in half-yearly profits, Arabian Business reported.
The company said it made USD30.16 million net profit during the January-June period, with gross profit up 5.6 percent to USD103.6 million.
The company also reported a 13.5 percent increase in sales to USD171.6 million during the first six months of 2012, including a 19.5 percent increase in tender market sales.
The biggest sales were realized in Saudi Arabia with USD32.4 million, followed by sales in the UAE with USD17 million, and Iraq with USD15.5 million, according to Julphar’s data.
In terms of tender market sales, Saudi Arabia also topped Julphar’s sales with USD16.9 million, followed by Iraq with USD4.84 million, and Jordan with USD4.25 million.
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more